Evofem Biosciences, Inc. · CIK 1618835
Evofem Biosciences, Inc.
These Form D notices describe private placements reported to the SEC. Read Form D/A amendments alongside the original disclosures.
Filings
2
Original notices
2
Amendments
0
Activity
Apr 15, 2025
through Jul 2, 2025
through Jul 2, 2025
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Differences between reported disclosures
Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.
| Field | Apr 15, 2025 · D | Jul 2, 2025 · D | Later minus earlier |
|---|---|---|---|
| Reported offering amount | $1,500,000 | $925,000 | $-575,000 |
| Reported amount sold | $750,000 | $925,000 | $175,000 |
| Reported investor count | — | — | — |
| Reported minimum investment | $0 | $0 | $0 |
Earlier SEC source: 0001641172-25-004770 · Later SEC source: 0001641172-25-017535
Choose filings to compare · Research this issuer step by step
Latest available filing snapshot: how to read these fields
- Reported offering amount
- $925,000
- Reported exemptions
- Rule 506(b)
- Reported amount sold
- $925,000
This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.
Form D filings (2)
-
0001641172-25-017535D · Jul 2, 2025 · BiotechnologyOffering: $925,000Sold: $925,000
Compared with 0001641172-25-004770:
- Reported offering amount: $1,500,000 → $925,000
- Reported amount sold: $750,000 → $925,000
-
0001641172-25-004770D · Apr 15, 2025 · BiotechnologyOffering: $1,500,000Sold: $750,000